LILLY ENDOWMENT INC 4
4 · ELI LILLY & Co · Filed Nov 26, 2025
Insider Transaction Report
Form 4
LILLY ENDOWMENT INC
10% Owner
Transactions
- Sale
Common Stock
2025-11-25$1108.71/sh−5,043$5,591,225→ 92,207,567 total - Sale
Common Stock
2025-11-25$1109.45/sh−9,249$10,261,294→ 92,198,318 total - Sale
Common Stock
2025-11-25$1110.53/sh−1,340$1,488,106→ 92,196,978 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,108.07 to $1,109.06, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), and (3) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,109.08 to $1,110.07, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,110.20 to $1,110.96, inclusive.